Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colleen M Feltmate

Showing results (21-30 of 50) with videos related to

Pageof 5
Sort By:
Gynecologic Oncology|April 3, 2012
The significance of preoperative leukocytosis in endometrial carcinomaMichael J Worley, Caroline C Nitschmann, Melina Shoni, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|January 4, 2018
Evaluation of AJCC and an Alternative Tumor Classification System for Primary Vulvar Squamous Cell CarcinomaSarah T Le, Pritesh S Karia, Beverley J Vollenhoven, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 29, 2025
Same-day discharge after minimally invasive hysterectomy for endometrial cancer and endometrial intraepithelial neoplasia in patients with morbid obesity: Safety and potential barriersEmily R Burdette, Andrea Pelletier, Micayla N Flores, et al.
Gynecologic Oncology|June 7, 2021
Risk of venous thromboembolism for ovarian cancer patients during first-line therapy after implementation of an Enhanced Recovery After Surgery (ERAS) protocolSue Li, Alexandra S Bercow, Michele Falzone, et al.
The Journal of Reproductive Medicine|August 28, 2010
Low-risk gestational trophoblastic neoplasia and methotrexate resistance: predictors of response to treatment with actinomycin D and need for combination chemotherapyWhitfield B Growdon, Adam J Wolfberg, Donald P Goldstein, et al.
Gynecologic Oncology|December 9, 2008
Evaluating methotrexate treatment in patients with low-risk postmolar gestational trophoblastic neoplasiaWhitfield B Growdon, Adam J Wolfberg, Donald P Goldstein, et al.
Gynecologic Oncology|August 5, 2014
Mucinous differentiation does not impact stage or risk of recurrence among patients with grade 1, endometrioid type, endometrial carcinomaMichael J Worley, Michelle Davis, Saba H Berhie, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 18, 2010
Evaluation of vascular space involvement in endometrial adenocarcinomas: laparoscopic vs abdominal hysterectomiesAnn K Folkins, Nicole S Nevadunsky, A Saleemuddin, et al.
Obstetrics and Gynecology|August 2, 2006
Low risk of relapse after achieving undetectable HCG levels in women with partial molar pregnancyAdam J Wolfberg, Whitfield B Growdon, Colleen M Feltmate, et al.
The Journal of Reproductive Medicine|December 15, 2006
Postevacuation hCG levels and risk of gestational trophoblastic neoplasia among women with partial molar pregnanciesWhitfield B Growdon, Adam J Wolfberg, Colleen M Feltmate, et al.
Pageof 5

Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
Gynecologic Oncology|April 3, 2012
The significance of preoperative leukocytosis in endometrial carcinomaMichael J Worley, Caroline C Nitschmann, Melina Shoni, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|January 4, 2018
Evaluation of AJCC and an Alternative Tumor Classification System for Primary Vulvar Squamous Cell CarcinomaSarah T Le, Pritesh S Karia, Beverley J Vollenhoven, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 29, 2025
Same-day discharge after minimally invasive hysterectomy for endometrial cancer and endometrial intraepithelial neoplasia in patients with morbid obesity: Safety and potential barriersEmily R Burdette, Andrea Pelletier, Micayla N Flores, et al.
Gynecologic Oncology|June 7, 2021
Risk of venous thromboembolism for ovarian cancer patients during first-line therapy after implementation of an Enhanced Recovery After Surgery (ERAS) protocolSue Li, Alexandra S Bercow, Michele Falzone, et al.
The Journal of Reproductive Medicine|August 28, 2010
Low-risk gestational trophoblastic neoplasia and methotrexate resistance: predictors of response to treatment with actinomycin D and need for combination chemotherapyWhitfield B Growdon, Adam J Wolfberg, Donald P Goldstein, et al.
Gynecologic Oncology|December 9, 2008
Evaluating methotrexate treatment in patients with low-risk postmolar gestational trophoblastic neoplasiaWhitfield B Growdon, Adam J Wolfberg, Donald P Goldstein, et al.
Gynecologic Oncology|August 5, 2014
Mucinous differentiation does not impact stage or risk of recurrence among patients with grade 1, endometrioid type, endometrial carcinomaMichael J Worley, Michelle Davis, Saba H Berhie, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 18, 2010
Evaluation of vascular space involvement in endometrial adenocarcinomas: laparoscopic vs abdominal hysterectomiesAnn K Folkins, Nicole S Nevadunsky, A Saleemuddin, et al.
Obstetrics and Gynecology|August 2, 2006
Low risk of relapse after achieving undetectable HCG levels in women with partial molar pregnancyAdam J Wolfberg, Whitfield B Growdon, Colleen M Feltmate, et al.
The Journal of Reproductive Medicine|December 15, 2006
Postevacuation hCG levels and risk of gestational trophoblastic neoplasia among women with partial molar pregnanciesWhitfield B Growdon, Adam J Wolfberg, Colleen M Feltmate, et al.
Pageof 5